Galena Biopharma (GALE) Adds to Early Gains After Confirming Regulatory Pathway to Advance GALE-401
Tweet Send to a Friend
Galena Biopharma, Inc. (NASDAQ: GALE) adds to early gains. Shares are now up 65 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
